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Abstract 
Introduction 
Uptake rates of antenatal vaccination remain suboptimal. Our aims were to determine: (1) the 
acceptability of routine vaccination among pregnant women, (2) the confidence of maternity 
healthcare professionals (HCPs) discussing vaccination and (3) HCP opinion regarding the optimum 
healthcare site for vaccine administration. 
 
Methods 
Separate questionnaires for pregnant women and HCPs were distributed within four NHS trusts in 
South England (July 2017-January 2018).  
 
Results 
Responses from 314 pregnant women and 204 HCPs (18% obstetricians, 75% midwives, 7% 
unidentified) were analysed. Previous/intended uptake of influenza and pertussis vaccination was 
78% and 92%, respectively. The commonest reason for declining vaccination was feared side-
effects for their child. White British women (79%) were significantly more accepting of influenza 
(85% vs. 61%, OR 3.25, 95% CI: 1.67-6.32) and pertussis vaccination (96% vs. 83%, OR 4.83, 95% CI: 
1.77-13.19) compared with non-white-British women. Among HCPs, 25% were slightly or not-at-all 
confident discussing vaccination. Obstetricians felt significantly more confident discussing pertussis 
vaccination than midwives (68% vs. 55% were very/moderately confident, OR 2.05, 95% CI: 1.02-
4.12). Among HCPs, 53%, 25% and 16% thought vaccines should be administered in primary care 
(general practice), community midwifery and in hospital, respectively.  
 
Conclusion 
Misconceptions exist regarding safety/efficacy of antenatal vaccination, and framing information 
towards the child’s safety may increase uptake. Education of HCPs is essential, and vaccine 
promotion should be incorporated into routine antenatal care, with an emphasis on women from 
ethnic minorities. Administration of vaccines in primary care presents logistical barriers however 
support for alternative sites appears low among HCPs.  
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Introduction  
 
Both influenza and pertussis result in severe outcomes for pregnant women and their infants 
(including respiratory illness and death) 1  2, and vaccination in pregnancy is an effective means of 
protection until the period of greatest susceptibility has passed  3–6. In the UK, influenza and 
pertussis vaccination have been routinely recommended for use in pregnancy since 2010 and 2012, 
respectively  7.  
 
Unfortunately, achieving vaccine acceptance among pregnant women and healthcare professionals 
(HCPs) remains a global challenge  8. The World Health Organization (WHO) Strategic Advisory 
Group of Experts on Immunization have called for improved monitoring of vaccine acceptance, and 
research into the socio-economic determinants of attitudes towards vaccines  9. The uptake of 
influenza and pertussis vaccination during pregnancy in England over the September 2016 - January 
2017 period was 44.9% and 74.2%, respectively  10  11. Pertussis vaccination uptake in the UK has 
gradually climbed from around 50% since its introduction in 2012, yet influenza vaccine uptake has 
been relatively static, and remains well below the WHO target of 75%  10. Furthermore, coverage 
varies significantly between different regions of the UK, with average uptake approximately 10% 
and 20% lower in London than in northern England for influenza and pertussis, respectively 9  11.  
 
Uptake of vaccination could be significantly improved if we are able to fully understand the 
decision-making processes to acceptance. Furthermore, it is well-acknowledged that 
encouragement from a familiar HCP significantly improves vaccine acceptance 12  13, yet few studies 
have considered the extent to which HCPs feel confident discussing vaccinations with pregnant 
women, and the associated factors which might influence this. Optimizing the healthcare site of 
vaccine administration is also an important issue that may have a considerable impact on vaccine 
uptake, yet few studies have considered the support of HCPs for alternative approaches. In the UK, 
vaccination is free-of-charge, and is usually provided within primary care (general practice), and is 
less commonly available within secondary (hospital-based) care. This may present a logistical 
barrier if it requires women to arrange extra appointments, and more convenient approach might 
be to routinely administer vaccination at the time of antenatal appointments. 
 
Ours aims were therefore: (1) to identify factors associated with the acceptance of influenza and 
pertussis vaccinations in pregnancy, (2) to establish the level of confidence among HCPs in 
discussing vaccination with pregnant women, as well as the factors which might affect this, and (3) 
to establish the opinion of HCPs as to the optimum healthcare site for vaccine administration. 
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Methods 
 
Questionnaire design and development 
Two separate anonymized questionnaires were developed for pregnant women and maternity 
HCPs. These were developed with input from a multi-disciplinary study team including 
obstetricians, pediatricians, health psychologists, and clinical academic trainees. The questionnaires 
consisted of closed questions and a single free-text box in which participants could add further 
comments.  
 
The questions analyzed here (see supplementary file) were nested within a larger questionnaire 
focussing on the attitudes of pregnant women and HCPs to both routine vaccination in pregnancy 
and to clinical trials of vaccines in pregnancy. The current paper focuses only on the questions 
relating to routinely recommended vaccines. Pregnant women were asked whether 1) they 
had/planned to receive influenza and pertussis vaccination and 2) the motivating reasons for 
accepting or declining these vaccines. Maternity HCPs were asked whether 1) they felt confident 
providing advice regarding these two vaccines and 2) their opinion regarding the optimal 
healthcare site of vaccine administration. Ethical approval was granted (reference 17/LO/0537) and 
the study was registered on ClinicalTrials.gov prior to recruitment (NCT03096574). 
 
Study population and recruitment 
The questionnaire for pregnant women was administered to women (aged > 16 years at the time of 
completing the questionnaire) attending for routine antenatal care at four study sites in southern 
England: University Hospital Southampton NHS Foundation Trust, University Hospitals Bristol NHS 
Foundation Trust, Oxford University Hospitals NHS Foundation Trust, and St George’s University 
Hospitals NHS Foundation Trust, London. These sites were selected because of their high birth rates 
(all > 4000 births/year)  14, and by distributing our questionnaire across four hospitals, we 
attempted to increase the demographic diversity of our study population. 
 
The HCP questionnaire was administered to those working in either midwifery or obstetrics at the 
same four study sites. It should be noted that routine antenatal care in the UK is usually midwife-
led (unless a pregnancy is deemed high-risk), and therefore the majority of potential respondents 
to our questionnaire were midwives, rather than obstetricians. Recruitment of participants took 
place from July 2017 to January 2018. Pregnant women were recruited in person via opportunistic 
sampling at antenatal clinics or wards, and given paper questionnaires to complete. Maternity HCPs 
were either recruited via email (containing a link to an online questionnaire) or face-to-face by 
opportunistic sampling, in which case they were also given paper questionnaires. The initial 
response rate from HCPs was promoted by up to two further email reminders. Participation was 
voluntary and no financial or other incentive was offered. All participants gave informed consent.  
 
Questionnaire data analysis 
Questionnaire data was entered at the lead site (Southampton) into iSurvey 
(www.isurvey.soton.ac.uk). Statistical analysis was performed using IBM SPSS Version 25. Logistic 
and ordinal regression analyses were performed for pregnant women and HCP responses, 
respectively, and adjusted odds ratios (ORs) were calculated. P-values <0.05 were considered as 
statistically significant. Multicollinearity was examined using the tolerance test and the Variance 
Inflation Factor (VIF) to ensure variables with a VIF value exceeding 2.5 were not entered into the 
multivariate regression analysis. 
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Results 
 
A total of 525 participants completed the questionnaires: 321 pregnant women and 204 HCPs (18% 
obstetricians, 75% midwives, and 7% unidentified). The numbers of respondents were relatively 
equally distributed between the four study sites. Eight questionnaires from pregnant women, and 
five from HCPs, were excluded due to largely incomplete or illegible responses, therefore 513 
questionnaires (98%) were included in the analysis. The full characteristics of respondents, 
including demographic details, are displayed in Table 1.  
 
Responses from pregnant women 
Regarding influenza vaccination: of 310 responses, 38% had been vaccinated, 40% were intending 
to be vaccinated, and 22% were not intending to be vaccinated. Regarding pertussis vaccination: of 
302 responses, 56% had been vaccinated, 36% were intending to be vaccinated, and 8% were not 
intending to be vaccinated. The reasons for declining vaccination are displayed in Figure 1. A similar 
trend in responses was observed for both vaccines. The most commonly cited reason for declining 
was concern about possible side effects for their child.  
 
Binary logistic regression analysis (Table 2, supplementary information) demonstrated that women 
identifying themselves as White British (79% of respondents) were significantly more likely to 
accept influenza (85% vs. 61%, OR 3.25, 95% confidence interval [CI] 1.67-6.32) and pertussis (96% 
vs. 83%, OR 4.83, 95% CI 1.77-13.19) vaccination compared to those identifying in all other ethnic 
groups. In the case of influenza vaccination, study site also had a significant effect, and participants 
at site B were significantly more likely to accept influenza vaccination than those at site D (91% vs. 
64%, OR 4.20, 95% CI 1.47-11.95). Participants’ age and whether they had previous children had no 
significant effect on vaccine uptake. In the qualitative analysis of the free text comments, pregnant 
women identified further concerns regarding vaccination in pregnancy, including damage to their 
unborn baby, vaccination being offered too late and insufficient information provided (see 
supplementary information). 
 
Responses from maternity healthcare professionals 
Out of 199 HCPs who responded, they were: extremely (25%), moderately (34%), somewhat (17%), 
slightly (16%) and not at all (8%) confident providing advice regarding influenza vaccination. For 
pertussis vaccination, they were: extremely (25%), moderately (32%), somewhat (16%), slightly 
(15%) and not at all confident (12%). See Figure 2. 
 
Ordinal regression analysis (Table 3, supplementary information) demonstrated that obstetricians 
were significantly more likely than midwives to feel confident giving advice about the pertussis 
vaccine (68% vs. 55% were very/moderately confident, OR 2.05, 95% CI 1.02-4.12), however there 
was no significant difference between either profession for the influenza vaccine. On the other 
hand, longer experience in maternity care was associated with greater confidence giving advice 
regarding influenza vaccination, but not pertussis vaccination. Study site was also significantly 
associated with confidence providing advice for both vaccines, with HCPs from sites B and C being 
significantly more likely to feel confident than those in site D. Finally, health professional’s age and 
whether or not they had children of their own were not associated with greater confidence in 
discussing vaccination. No free-text comments from staff relating to influenza/pertussis vaccination 
were provided for analysis. 
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With regards to the optimal healthcare site for vaccine administration during pregnancy (Figure 3), 
approximately one-half (53%) of HCP respondents thought that vaccines should be delivered in the 
primary care setting as part of general practice, 25% thought vaccines should be delivered in by 
midwives in the community, and 16% thought vaccines should be delivered in secondary care (at 
the time of antenatal appointments). The remaining 8% either thought that vaccination should be 
administered in both general practice and community midwifery services (4%) or in all three 
locations (4%). 
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Discussion 
 
Vaccination in pregnancy remains a national and international priority for improving healthcare 
outcomes. Understanding women's and HCP’s opinions and attitudes to vaccine acceptance are 
important in explaining current vaccination attainment levels. Our aims were to identify factors 
associated with vaccine acceptance and hesitancy among pregnant women, to establish whether 
HCPs feel confident discussing vaccination with these women, and to establish where HCPs thought 
these vaccines should be administered. 
 
Uptake of vaccination among pregnant women 
Encouragingly, the acceptance of influenza and pertussis vaccination was high among pregnant 
women in this study. The most common reasons for vaccine hesitancy were concerns about side 
effects, and doubts regarding the effectiveness and need for vaccination. Perception of possible 
harm is commonly cited as the primary reason for vaccine refusal among previous studies  12  15, and 
women are usually more concerned about potential risks to their child’s health than their own 16. 
Clearly, important misconceptions still exist regarding the safety of vaccines, including the presence 
of ‘toxins’ such as thimerosal (a mercury-containing preservative removed from childhood vaccines 
in 2001) that was proposed in 2005 to be associated with neurologic conditions, including autism 17. 
We recommend that vaccine advocacy should emphasise the safety and efficacy of vaccination, 
specifically towards protection of the baby. Furthermore, accessible alternatives to face-to-face 
counseling that been successfully used in the past have included social media and webcasts  18  19, 
mobile phone text messages (such as Text4baby) 20  21 and smart phone apps (such as MatImms 22). 
 
Another important finding was that pregnant women of ethnic minorities were significantly less 
likely to accept vaccination than those identifying as ‘White British’. Previous research has similarly 
demonstrated lower vaccine acceptance among these groups  23–25, and these findings highlight the 
importance of taking into account possible cultural/religious and language barriers when 
counselling these women and producing educational materials. The underlying reasons for the 
difference in vaccine attitudes between ethnic groups remains a significant gap in our knowledge, 
and future studies in this specific area are needed. Interestingly, we did not find any significant 
effect of age or having children already in our study, however younger age has been shown to be 
associated with lower uptake in some previous studies  23  26. Study site had no effect on pertussis 
vaccine acceptance however there was significantly higher influenza vaccine acceptance among 
pregnant women at site B.  These results may be skewed by the recruitment season of this site, 
however, as recruitment here was all undertaken entirely during the influenza vaccination season 
(which runs from September to February). 
 
Confidence of healthcare professionals and optimal healthcare site for vaccine administration 
Very few previous studies  27 have investigated to what extent HCPs feel confident discussing 
vaccination with pregnant women. This is despite the fact that pregnant women consider their HCP 
their most trusted source of information, and encouragement from them has been shown to 
increase intention to receive vaccination by up to 20 times  13  12. Conversely, a lack of knowledge of 
the indications and benefits of vaccination among HCPs has been identified as a barrier to 
implementation of vaccination recommendations  28. Among HCPs in our study, a significant 
proportion were not confident providing advice to pregnant women. Confidence also varied 
significantly by study site, suggesting that there is a potential risk of health inequalities based on 
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differing levels of vaccine confidence and recommendations across the South of England. Further 
education of multidisciplinary HCPs is essential, and individual barriers to active promotion of these 
vaccines need to be identified and reduced. Individual sites should aim to establish areas of low 
confidence within their own working body and push to incorporate active promotion of vaccination 
into routine antenatal care. Also, while it should be noted that obstetricians, and those with more 
experience in maternity care, felt more confident giving advice about the pertussis and influenza 
vaccines, respectively, we suggest that education should not be aimed solely at a particular 
profession, or those new to maternity care.  
 
Finally, optimizing the healthcare site for vaccine administration is an important and topical issue 
which may have a considerable impact on vaccine uptake. In the UK, vaccination in pregnancy is 
usually provided in the primary care setting (within general practice), yet this presents a logistical 
barrier as it normally requires women to arrange extra primary care appointments. A more 
convenient and efficient approach might be to routinely offer and administer vaccination at the 
time of hospital antenatal appointments (such as the fetal anomaly scan at around 20 week’s 
gestation), either by incorporating vaccination directly into these clinics, or providing adjacent 
vaccination clinics, which women are invited to visit immediately before or after their regular 
antenatal appointment  29–31. Previous studies have demonstrated that vaccinating in secondary 
care may indeed improve uptake  29–31, yet support for this approach appeared to be low (16%) 
among HCPs surveyed in this study. A lack of staff, lack of a suitable setting and resources, concerns 
regarding appropriate financial reimbursement, and lack of confidence with vaccine discussion, 
have all been identified as potential barriers to this approach by HCPs in previous studies  30–33. 
Potential solutions include employing dedicated vaccination staff (including vaccination specialist 
midwives) and improving vaccine education (as discussed above). Further pragmatic and/or 
qualitative research is also required to establish the feasibility and effectiveness of this approach, 
and to establish facilitators and barriers to its acceptance among both pregnant women and HCPs. 
 
Strengths and limitations 
This study had significant numbers of respondents, and by distributing our questionnaire at four 
hospitals in southern England we attempted to maximize the demographic diversity of our study 
population. That said, the responses to the questionnaire cannot be taken as representative of all 
pregnant women and maternity HCPs. Reported actual/intended vaccine uptake was higher among 
our questionnaire respondents than national reports of vaccine uptake, and this may limit the 
generalisability of our study findings. All of our respondents were recruited from antenatal clinics at 
tertiary hospitals, and therefore it is possible that our sample was missing subsets of the population 
that tend to be more anti-vaccination. Future studies would therefore benefit from including a 
greater number of study sites over a wider geographic area, and recruiting from different types of 
sites (including smaller non-tertiary hospitals and primary care) and perhaps utilizing online 
recruitment via popular websites and social media. 
 
Another limitation is that we relied upon self-reported vaccination status/intention, and there is 
therefore potential reporting bias in our estimations, which may have been improved by 
verification of women’s medical records following delivery; however recent evidence does suggest 
that self-reported intention correlates well with actual uptake of vaccination  34  35. Finally, the 
number of pregnant women/HCPs approached, and the number who declined participation (as well 
as their reasons for doing so) was not recorded, and we are therefore unable to report this. 
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Conclusions 
Whilst the high acceptance of vaccination among respondents in this study was encouraging, 
misconceptions still exist regarding vaccine safety and efficacy. Further education of 
multidisciplinary HCPs is essential, and active vaccine promotion needs to be incorporated into 
routine antenatal care, with a particular emphasis on women from ethnic minorities.  
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Figures 
Figure 1: Reasons why the surveyed pregnant women did not intend to receive influenza or 
pertussis vaccination in pregnancy 
 
Figure 2: Healthcare professionals’ confidence providing advice to pregnant women regarding 
influenza (A) and pertussis (B) vaccination in pregnancy 
 
Figure 3: Healthcare professionals’ opinions regarding the optimal healthcare site at which vaccines 
in pregnancy should be delivered  
 
Tables 
Table 1: Characteristics of the respondents to questionnaires (pregnant women and healthcare 
professionals) 
 
Table 2 [Supplementary information]: Logistic regression analysis of factors predicting pregnant 
women’s intention to receive vaccination  
 
Table 3 [Supplementary information]: Ordinal regression analysis of factors predicting healthcare 
professionals’ confidence in providing advice regarding vaccination in pregnancy  
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Table 1: Characteristics of the respondents to questionnaires (pregnant women and maternity 
healthcare professionals) 
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*= p<0.05; **= p<0.01; ***= p<0.001; 
 
Table 2: Logistic regression analysis of factors predicting pregnant women’s intention to 
receive/previous receipt of vaccination  
 
 
 
 
*= p<0.05; **= p<0.01; ***= p<0.001 
 
Table 3: Ordinal regression analysis of factors predicting healthcare professionals’ confidence in 
providing advice regarding vaccination in pregnancy 
 
 
 
 
  16 
 
 
 
Figure 1: Reasons why the surveyed pregnant women did not intend to receive influenza or 
pertussis vaccination in pregnancy 
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Figure 2: Healthcare professionals’ confidence providing advice to pregnant women regarding 
influenza (A) and pertussis (B) vaccination in pregnancy 
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Figure 3: Healthcare professionals’ opinions regarding the optimal healthcare site at which vaccines 
in pregnancy should be delivered  
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Supplementary information 
 
 
1. Questions for pregnant women analyzed in this study 
 
(1) Have you received either of the following vaccines in this pregnancy?  
Flu (influenza)    ☐ Yes   ☐ No 
Whooping cough (pertussis)  ☐ Yes   ☐ No 
 
 (1a) If no, why have you not yet received these vaccines? 
 
     For flu (influenza)?     For whooping cough(pertussis)? 
 
I don’t intend to receive the vaccine ☐    ☐ 
I haven’t been offered the vaccine yet  ☐    ☐ 
I haven’t got round to getting the vaccine yet☐    ☐ 
Other (please 
specify)…………………………………………………………………………………………………………….. 
 
 
(1b) If you don’t intend to receive these vaccines in this pregnancy, please specify the reasons why. Tick 
as many apply: 
 
For flu (influenza)?     For pertussis (whooping cough)? 
 
I worry that the injection might be painful  ☐    ☐ 
My midwife did not advise it    ☐    ☐ 
My obstetrician did not advise it   ☐    ☐ 
My GP did not advise it    ☐    ☐ 
My family/friends advised against it   ☐    ☐ 
I don’t believe the vaccine is effective   ☐    ☐ 
I worry about potential side effects for my baby ☐    ☐ 
I worry about potential side effects for me  ☐    ☐ 
Vaccination was not offered to me   ☐    ☐ 
There is not enough safety data   ☐    ☐ 
I don’t have enough information to decide  ☐    ☐ 
I am concerned about information in the media ☐    ☐ 
I don’t want to attend extra hospital/GP visits ☐    ☐ 
Religious or other convictions   ☐    ☐ 
Other (please specify): 
………………………………………………………………………………………………………………………………
……….. 
(2) How old are you in years? 
16-24 ☐  25-30 ☐ 31-35 ☐ 36-40 ☐ 41-45 ☐ 46+ ☐  
  
 
(3) How many weeks pregnant are you? 
Less than 12 ☐  12-16 ☐ 17-20 ☐ 21-30 ☐ 31-36 ☐ 37+ ☐  
 
 
(4) To what ethnic group do you feel you belong? (Please circle) 
 
White      Black / African / Caribbean / Black British 
- English / Welsh / Scottish / Northern Irish - African  
  20 
/ British Irish      - Caribbean  
- Gypsy or Irish Traveller    - Other (please specify)…………………………….. 
- Other (please specify) …………………………….. 
 
Mixed/Multiple ethnic groups  Other ethnic group 
- White and Black Caribbean    - Arab  
- White and Black African    - Other (please specify)………………………… 
- White and Asian  
- Other (please specify) …………………………….. 
 
Asian / Asian British    I’d prefer not to say 
- Indian  
- Pakistani  
- Bangladeshi  
- Chinese  
- Other (please specify) ………………………… 
 
 
(5) Have you had any children before?   
☐ Yes. 
If yes, how many?.................................................................... 
What are their ages? 
Child 1: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐  
Child 2: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐ 
Child 3: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐  
☐ No  
 
 
 
(6) Optional: Do you have any comments or concerns about any of the issues raised in the questionnaire?  
………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………
……………………………………………… 
………………………………………………………………………………………………………………………………
……………… 
 
 
2. Questions for maternity healthcare professionals analyzed in this study 
 
 
(1) How confident would you feel about providing advice regarding the flu (influenza) vaccine to women during 
pregnancy? 
☐ Not at all confident  
☐ Slightly confident 
☐ Somewhat confident 
☐ Moderately confident 
☐ Extremely confident 
 
 
(2) How confident would you feel about providing advice regarding the whooping cough (pertussis) vaccine to 
women during pregnancy? 
☐ Not at all confident 
☐ Slightly confident 
☐ Somewhat confident 
☐ Moderately confident 
☐ Extremely confident 
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(3) In your opinion, where should these vaccines be delivered to pregnant women?   
 
☐ Primary care (GP practice) 
☐ Midwifery services (Community services) 
☐ Secondary care at time of antenatal scans or appointments 
☐ Other (please specify)………………………………………………………………………………………………….. 
 
(4) Which healthcare professional group do you belong to?       
☐ Obstetrics 
☐ Midwifery 
☐ Other (please state) ………………………………………………………………………………………… 
 
 
(5) How long have you worked in maternity care? 
☐ Under 2 years 
☐ 2-5 years 
☐ 6-10 years  
☐ 11-15 years 
☐ 16-20 years  
☐ 21+ years  
 
(6) What is your grade? 
1. Midwifery/nursing staff 
Band 4 ☐       Band 5 ☐       Band 6 ☐         Band 7 ☐        Band 8 ☐        Band 9 ☐ 
2. Obstetricians 
ST 1-3 (or equivalent) ☐     ST 4-6 (or equivalent) ☐      ST 7-8 (or equivalent) ☐     Consultant ☐ 
 
(7) Have you had any children before?   
☐ Yes. 
If yes, how many?.................................................................... 
What are their ages? 
Child 1: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐  
Child 2: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐ 
Child 3: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐  
Child 4: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐   
  
☐ No  
  
(8) To what ethnic group do you feel you belong? (Please circle) 
 
White     Black / African / Caribbean / Black British 
- English / Welsh / Scottish / Northern Irish - African  
/ British Irish     - Caribbean  
- Gypsy or Irish Traveller    - Other (please specify)…………………………….. 
- Other (please specify) …………………………….. 
 
Mixed/Multiple ethnic groups  Other ethnic group 
- White and Black Caribbean   - Arab  
- White and Black African    - Other (please specify)………………………… 
- White and Asian  
- Other (please specify) …………………………….. 
 
Asian / Asian British   I’d prefer not to say 
- Indian  
- Pakistani  
- Bangladeshi  
- Chinese  
- Other (please specify) ………………………… 
  22 
 
 
(9) Optional: Do you have any comments or concerns about vaccination or vaccine research studies during 
pregnancy?  
………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………
…………………………………………………… 
 
 
3. Free text comments (all received from pregnant women) 
 
“Many vaccines contain unsafe levels of mercury, in some cases are produced on human tissue 
(DNA) and contain various other toxins. I believe a baby is born with a perfect immune system which 
takes up to three years to fully develop and it’s not healthy injecting a perfectly healthy child with 
chemicals and toxins (mercury)”  
 
“We were not offered the whooping cough [vaccine] until much later on in the pregnancy – close to 
it being too late. No flu jab offered – we would have done so otherwise.” 
 
“I would like the opportunity to ask more questions and have more information before agreeing to 
vaccination” 
 
